Michela Garofalo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
128
Citations
8,709
Est. group size
—
Recurring co-author estimate
Active years
45
Publishing since 1981
Michela Garofalo's research focuses on non-coding RNAs, such as microRNAs and long non-coding RNAs, and their roles in cancer, particularly lung cancer and medulloblastoma (a type of brain tumor). Work in this area examines how these RNA molecules and related proteins regulate tumor cell growth, spread (metastasis), and resistance to treatment. The publication record also includes studies on RNA changes in cerebrospinal fluid of pediatric spinal muscular atrophy patients following treatment.
Publication output was relatively steady at 4-5 papers per year from 2017-2022, spiked sharply to 32 in 2023 (likely including many supplementary dataset entries tied to a single paper), then dropped to just 1 per year in 2024 and 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Scientific Reports · 2025
- Editorial Expression of Concern: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Oncogene · 2024
- Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer
Cell Death and Differentiation · 2023
- Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen
Biology Direct · 2023
- Supplementary Table 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 4 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- fullscanofwesternblots.pptx from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 2 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Table 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 2 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Figure 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Supplementary Data from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023
- Cancer Cell×4
- Cell Death and Differentiation×3
- Scientific Reports×3
- European Urology Supplements×3
- Nature Communications×2
- Jing Peng
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jia Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Carlo M. Croce
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Francesca Lovat
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Xinna Zhang
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile